Study of [68Ga]-FF58 in Patients With Selected Solid Tumors Expected to Overexpress αvβ3 and αvβ5 Integrins.
Novartis
Novartis
Five Prime Therapeutics, Inc.
University of Pennsylvania
Oncolytics Biotech
Inova Health Care Services
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of California, San Diego
National Institutes of Health Clinical Center (CC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Vanderbilt-Ingram Cancer Center
Stanford University
University of Arizona
Swedish Medical Center